Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France

NCT ID: NCT04900376

Last Updated: 2023-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-15

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this non-interventional, multi-center study is to compare the incidence of serious health events (death, unscheduled hospitalizations) in subjects vaccinated against Coronavirus with that of unvaccinated subjects, in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-De-France during the same observation period 12-months minimun and up to18 months according vaccinal schedule.

The primary outcome will be the incidence of serious health events (death and unscheduled hospitalizations) in subjects vaccinated against Coronavirus compared to that of unvaccinated subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multicenter study is a parallel cohort to the first phase of the vaccination campaign against Coronavirus, in particular for elderly subjects in institutions. All subjects who will not oppose the study will be included and this date will correspond to Day 0.

D0 will correspond to the date of the first vaccine injection for subjects in the vaccine group.

The subjects included will be followed up on D21, D90, M6, 12 months (M12) and up to 18 months in the case of 3rd vaccinal injection

The following data will be collected at inclusion and during follow-up:

* Age, weight, sex, level of autonomy
* Chronic diseases
* Any hospitalizations
* Possible symptoms after vaccination for subjects who choose to be vaccinated
* The fate of the subjects and the evaluation of the immune response
* Hospitalizations and vital status of subjects

Serology data prescribed by doctors as part of routine care will also be collected.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Reside Either in Retirement Home or Long-term Care Units

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

vaccinated group

No interventions assigned to this group

unvaccinated group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject in Retirement Home (EHPAD) or Long-term Care Units (USLD) during the anti-Coronavivus vaccination period.
* Subject not opposing the study or whose legal representative does not oppose the study.

Exclusion Criteria

* Subject not affiliated to a social security scheme.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gérond'if

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier Hanon, MD PhD

Role: STUDY_CHAIR

Geriatric Department, Broca hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geriatric Department, Broca Hospital

Paris, IIe-de-France, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Isabelle Dufour

Role: CONTACT

+33 (0)185781010

Adrien Besseiche

Role: CONTACT

+33 (0)185781010

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Olivier Hanon, MD PhD

Role: primary

+33 (0)144083503

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00007-34

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study Human Digital Support Transitional Care
NCT06354166 NOT_YET_RECRUITING NA